These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27793354)

  • 1. Continuous Subcutaneous Insulin Infusion as an Effective Method of Desensitization Therapy for Diabetic Patients with Insulin Allergy: A 4-year Single-center Experience.
    Yuan T; Zhao W; Wang L; Dong Y; Li N
    Clin Ther; 2016 Nov; 38(11):2489-2494.e1. PubMed ID: 27793354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin allergy desensitization with simultaneous intravenous insulin and continuous subcutaneous insulin infusion.
    Neville KA; Verge CF; Wainstein BK; Woodhead HJ; Ziegler JB; Walker JL
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):420-2. PubMed ID: 18775000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus.
    Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G
    J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Experience with U-500 Regular Insulin by Multiple Daily Injections and Continuous Subcutaneous Insulin Infusion.
    Meade LT; Tart RC; Nuzum D
    Diabetes Technol Ther; 2017 Apr; 19(4):220-225. PubMed ID: 28249123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
    Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource utilization with insulin pump therapy for type 2 diabetes mellitus.
    Lynch PM; Riedel AA; Samant N; Fan Y; Peoples T; Levinson J; Lee SW
    Am J Manag Care; 2010; 16(12):892-6. PubMed ID: 21348559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review.
    Elfekih H; Hadjkacem F; Elleuch M; Ghorbel D; Charfi N; Mnif F; Rekik N; Mnif M; Abid M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):572-583. PubMed ID: 32245301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.